
Oneview Healthcare
Oneview Healthcare provides a software platform for healthcare organizations to improve cost efficiencies, clinical outcomes, and patient satisfaction. Their platform connects patients, families, and caregivers with access to information, entertainment, and communication tools at the point of care, aiming to enhance the overall healthcare experience.
Short position
Oneview Healthcare (ASX:ONE) has 1.17% of its shares on issue reported as short positions as of 5 Oct 2026, or about 9,816,854 shares. Over the past 30 days that figure has been broadly flat, and over 90 days it has been broadly flat. Its highest recorded short interest was 3.40% in July 2023. ONE is classified in the Health Care Equipment & Services industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4Oneview Healthcare (ONE) financials
Results, ratios and statements
Latest result
12 months to 30 Jun 2026 (TTM Jun 26) vs TTM Jun 25, figures in EUR, the reporting currency
- Revenue
- 11.1Mvs n/a (TTM Jun 25)
- Yahoo Finance, as at 29 Sep 2026
- NPAT
- −10.2Mvs n/a (TTM Jun 25)
- Yahoo Finance, as at 29 Sep 2026
- EPS (diluted)
- −0.017vs −0.016 (TTM Jun 25)
- Yahoo Finance, as at 29 Sep 2026
- Rev YoY
- +21.3%FY
- EPS YoY
- n/aTTM
Key ratios
12 months to 30 Jun 2026 (TTM); balance sheet at 31 Dec 2025, 6 months before; prices to 9 Oct 2026
- Gross margin
- 68.8%
- Operating margin
- −94.9%
- Net margin
- −91.5%
- FCF margin
- −70.6%
- ROE
- −120.7%
- ROA
- −49.2%
- FCF conversion
- n/a
- Net cash (excl. leases)
- EUR 4.6M
- Net debt / EBITDA
- n/a
- Current ratio
- 1.3×
- Interest cover
- −6.8×
- Cash dividends paid / net profit
- n/a
- Market cap
- $107.4M
- P/E
- n/a (reports in EUR)
- P/B
- n/a (reports in EUR)
Ratios use the reporting currency (EUR); market cap is in AUD. Source: Yahoo Finance, as at 29 Sep 2026.
Financial statements
Figures in EUR, the reporting currency; Yahoo Finance unless marked
| Line item | TTM Jun 26 | FY25 | FY24 | FY23 | FY22 |
|---|---|---|---|---|---|
| Revenue | 11.1M | 12.0M | 9.9M | 9.4M | 8.9M |
| Gross profit | 7.7M | 7.7M | 6.7M | 6.2M | 5.3M |
| Operating income | −10.6M | −11.6M | −11.9M | −8.9M | −12.9M |
| EBITDA | −8.1M | −10.5M | −10.1M | −7.9M | −10.1M |
| EBIT | −8.6M | −11.0M | −10.6M | −8.4M | −10.8M |
| Interest expense | 1.5M | 1.5M | 150.4K | 517.0K | 162.5K |
| Pretax income | −10.1M | −12.5M | −10.8M | −8.9M | −10.9M |
| Tax | 54.0K | 53.0K | 63.6K | 49.7K | −55.2K |
| NPAT | −10.2M | −12.6M | −10.8M | −8.9M | −10.9M |
| Net interest income | −1.5M | −1.5M | −18.7K | −511.8K | −172.4K |
| EPS basic | −0.017 | −0.017 | −0.016 | −0.015 | −0.020 |
| EPS diluted | −0.017 | −0.017 | −0.016 | −0.015 | −0.020 |
| Shares | n/a | 767.2M | 760.5M | 671.5M | 535.0M |
Financial reports
The company's own filings, newest first
- Half Yearly Report and AccountsHalf Year Results27 Aug 2026via asx_announcements
- Half Year 2026 Investor PresentationHalf Year Results27 Aug 2026via asx_announcements
- Quarterly Activities/Appendix 4C Cash Flow ReportQuarterly Report29 Jul 2026via asx_announcements
- Quarterly Activities/Appendix 4C Cash Flow ReportQuarterly Report27 Apr 2026via asx_announcements
- Annual Report to shareholdersAnnual Report26 Mar 2026via asx_announcements
- Investor Presentation - Preliminary Final Report 2025Annual Results12 Feb 2026via asx_announcements
- Preliminary Final ReportAnnual Results12 Feb 2026via asx_announcements
- Quarterly Activities/Appendix 4C Cash Flow ReportQuarterly Report15 Jan 2026via asx_announcements
- Quarterly Activities/Appendix 4C Cash Flow ReportQuarterly Report30 Oct 2025via asx_announcements
- Half Yearly Report and AccountsHalf Year Results13 Aug 2025via asx_announcements
Showing 10 of 26 reports